Equity Mates Investing Podcast cover image

The drug beating Ozempic, Pimp my Portfolio with Luke Laretive & Australia's most popular small caps

Equity Mates Investing Podcast

00:00

Australia's GLP-1 adoption and drug competitors

Hosts compare US and Australian uptake and introduce the Novo vs Eli Lilly competition in GLP-1 drugs.

Play episode from 05:53
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app